IZCZ-3 is a potent c-MYC transcription inhibitor with antitumor activity In Vitro IZCZ-3 (2.1 μM-15.9 μM; 24 hours) significantly inhibits SiHa, HeLa, Huh7, and A375 cancer cell proliferation (IC 50 s of 3.3, 2.1，4.1, and 4.2 μM, respectively). IZCZ-3 induces only weak growth inhibition in the BJ fibroblasts (IC 50 =15.9 μM) and mouse mesangial cells (IC 50 =15.6 μM), suggesting that IZCZ-3 is more effective against cancer cells than against c-MYC-independent normal cells. IZCZ-3 (0-5 μM; 12 hours) induces an apparent accumulation of cells in the G0/G1 phase in SiHa cells in a dose-dependent manner. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Cell Proliferation AssayCell Line: SiHa, HeLa, Huh7, and A375 cancer cells (with overexpression of c-MYC protein) and in normal BJ fibroblasts and primary cultured mouse mesangial cells (with relatively low expression of c-MYC protein). Concentration: 2.1 μM-15.9 μM Incubation Time: 24 hours Result: IC 50 s of 3.3, 2.1，4.1, and 4.2 μM for SiHa, HeLa, Huh7, and A375 cancer cells; IC 50 s of 15.9 μM and 15.6 μM for BJ fibroblasts and mouse mesangial cells. Cell Cycle AnalysisCell Line: SiHa cells Concentration: 0, 1.25, 2.5, and 5 μM Incubation Time: 12 hours Result: Induced an apparent accumulation of cells in the G0/G1 phase (increasing from 61% to 70%) in a dose-dependent manner. In Vivo IZCZ-3 (20, 10, and 5 mg/kg; intraperitoneally; every other day for 24 days) inhibits tumor growth in BALB/c nude mice with SiHa human cervical squamous cancer xenograft . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: BALB/c nude mice (5 weeks old) bearing SiHa human cervical squamous cancer xenograft model Dosage: 20, 10, and 5 mg/kg Administration: Treated intraperitoneally; every other day for 24 days Result: Treatment with 20, 10, and 5 mg/kg resulted in a significant reduction in tumor weight with tumor growth inhibition (TGI) of 69%, 64%, and 57%, respectively. Displayed time-dependent inhibition of tumor growth. Form:Solid IC50& Target:c-MYC transcription
All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry
IZCZ-3
CAS number：2223019-53-0 molecular formula：C46H49N7O
overview
compound introduction
Specs
| Chinese alias | 伊兹楚-3 | ||
| English alias | - | ||
| CAS number | 2223019-53-0 | molecular formula | C46H49N7O |
| molecular weight | 715.93 g/mol | Exact mass | ≥98% |
| PSA | - | logp | - |
numbering system
No numbering system information yet
physicochemical properties
No physical and chemical property information yet
Safety information
No safety information yet
Production methods and uses
No production method and use information yet
Related
upstream information
No upstream information yet
downstream information
No downstream information yet
MSDS
Found 0 shareMSDS
